Siemens Healthineers AG (OTCMKTS:SMMNY – Get Free Report) saw a large drop in short interest in the month of October. As of October 15th, there was short interest totaling 69,756 shares, a drop of 48.9% from the September 30th total of 136,510 shares. Based on an average daily volume of 111,519 shares, the days-to-cover ratio is presently 0.6 days.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on the stock. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Siemens Healthineers in a research report on Friday, October 16th. Zacks Research cut shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 1st. Citigroup reaffirmed a “buy” rating on shares of Siemens Healthineers in a report on Tuesday, October 13th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Siemens Healthineers in a research note on Tuesday, August 18th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy”.
Get Our Latest Stock Analysis on Siemens Healthineers
Siemens Healthineers Stock Down 0.7%
OTCMKTS:SMMNY opened at $23.81 on Friday. The business’s 50-day moving average price is $22.43 and its 200 day moving average price is $22.00. Siemens Healthineers has a 52-week low of $19.20 and a 52-week high of $28.43.
Siemens Healthineers Company Profile
Siemens Healthineers AG is a global medical technology company headquartered in Erlangen, Germany. The company develops, manufactures and provides products, services and digital solutions that support the prevention, diagnosis and treatment of disease. Siemens Healthineers operates as a separately managed company within the broader Siemens group and has served healthcare providers in markets around the world.
Its portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, X-ray and molecular imaging equipment, as well as ultrasound systems.
Further Reading
- Five stocks we like better than Siemens Healthineers
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.
